U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07057765) titled 'Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL' on June 02.
Brief Summary: This observational study evaluates the predictive value of systemic inflammatory markers-CRP, albumin, CRP-to-albumin ratio (CAR), and modified Glasgow Prognostic Score (mGPS)-in patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP chemotherapy. The study examines associations with treatment response, toxicity, and clinical characteristics.
Study Start Date: May 05
Study Type: OBSERVATIONAL
Condition:
DLBCL - Diffuse Large B Cell Lymphoma
Markers of Inflammation
Intervention:
DRUG: Observational Assessment...